title: Secondary hyperparathyroidism in HIV patients: is there any responsibility of highly active antiretroviral therapy?
abstract: Secondary hyperparathyroidism may develop in the presence of hypovitaminosis D in order to maintain calcium homeostasis. We conducted a cross-sectional analysis in a cohort of 371 patients, identifying secondary hyperparathyroidism in 65 patients. This high prevalence (17.5%) was in part justified by the high prevalence of hypovitaminosis D (77.4%) in the whole sample, but we also identified an independent association with the use of tenofovir.
authors: Department of Infectious Diseases, Luigi Sacco Hospital, Milan, Italy. pocaterra.daria@hsacco.it
authors: Daria
authors: D
authors: Pocaterra
authors: Laura
authors: L
authors: Carenzi
authors: Elena
authors: E
authors: Ricci
authors: Davide
authors: D
authors: Minisci
authors: Monica
authors: M
authors: Schiavini
authors: Paola
authors: P
authors: Meraviglia
authors: Maurizio
authors: M
authors: Bevilacqua
authors: Patrizia
authors: P
authors: Zucchi
authors: Paolo
authors: P
authors: Bonfanti
authors: Giuliano
authors: G
authors: Rizzardini